APA (7th ed.) Citation

Yuda, J., Will, C., Phillips, D. C., Abraham, L., Alvey, C., Avigdor, A., . . . Souers, A. J. (2023). Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients. Communications Medicine, 3(1), . https://doi.org/10.1038/s43856-023-00380-z

Chicago Style (17th ed.) Citation

Yuda, Junichiro, et al. "Selective MCL-1 Inhibitor ABBV-467 Is Efficacious in Tumor Models but Is Associated with Cardiac Troponin Increases in Patients." Communications Medicine 3, no. 1 (2023). https://doi.org/10.1038/s43856-023-00380-z.

MLA (9th ed.) Citation

Yuda, Junichiro, et al. "Selective MCL-1 Inhibitor ABBV-467 Is Efficacious in Tumor Models but Is Associated with Cardiac Troponin Increases in Patients." Communications Medicine, vol. 3, no. 1, 2023, https://doi.org/10.1038/s43856-023-00380-z.